Experimental Therapy Simultaneously Destroys Prostate Tumor Cells and Reactivates Antitumor Immunity
In a groundbreaking preclinical study, researchers at Weill Cornell Medicine and the Cornell Duffield College of Engineering have unveiled a ...
In a groundbreaking preclinical study, researchers at Weill Cornell Medicine and the Cornell Duffield College of Engineering have unveiled a ...
In a groundbreaking advancement for prostate cancer treatment, researchers led by Radboud University Medical Center (Radboudumc) have unveiled promising results ...
In a significant advancement for prostate cancer diagnostics, the recent findings from the PRIMARY2 clinical trial reveal that PSMA PET/CT ...
Lutetium-177-PSMA-617 (Pluvicto®) has emerged as a groundbreaking radiolabeled therapeutic agent in the battle against advanced prostate cancer, specifically targeting metastatic ...
A groundbreaking clinical investigation has revealed a transformative approach in the management of recurrent prostate cancer presenting with limited metastatic ...
In the continuous quest to enhance precision in cancer surgeries, a groundbreaking development has emerged from the University of British ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine